SCOOP: Remember Ambrosia? The controversial startup is once again offering young blood transfusions.
“This treatment is available now. Trials are very expensive, and they take a really long time. I’m comfortable with going ahead and offering this treatment commercially to patients.” By
An exclusive: Ambrosia, the Young Blood Transfusion Startup, Is Quietly Back in Business
💉OZ EXCLUSIVE💉 Ambrosia, the startup that administered transfusions of young blood for anti-aging purposes, is quietly back in business after the FDA issued a statement about the company earlier this year. here's with the BIG SCOOP!
EXCLUSIVE: Ambrosia, the much-maligned startup selling blood transfusions from young donors, is back up and running.
Welp, not really. Here’s with a KILLER scoop: Ambrosia, out of the public eye, has resumed offering transfusions “Our patients really want the treatment” the CEO told her. Ambrosia, the Young Blood Transfusion Startup, Is Back in Business
Here's a flip. The young plasma transfusion to old for rejuvenation (now back up: ) Ugh. Now old gut #microbiome to young for #brain, lifespan benefit
SCOOP from Ambrosia, the company selling young blood to older people, has quietly resumed business after an FDA warning letter earlier this year
SCOOP from Ambrosia, the company selling young blood to older people, has quietly resumed business after an FDA notice warned consumers against getting these transfusions earlier this year
Ambrosia, the young blood transfusion startup, is quietly back in business. Reminds me so much of Theranos.
#AmbrosiaPlasma , the Young Blood Transfusion Startup, Is Quietly Back in Business: The company says it paused operations after an notice, but customer demand remained high via